Quarterly report [Sections 13 or 15(d)]

STOCKHOLDERS??? EQUITY (Tables)

v3.25.2
STOCKHOLDERS’ EQUITY (Tables)
3 Months Ended
Jul. 31, 2025
Equity [Abstract]  
SCHEDULE OF ACTIVITY RESTRICTED AND DEFERRED STOCK UNITS

A summary of the changes in RSUs and DSUs outstanding during the three months ended July 31, 2025 follows:

 

SCHEDULE OF ACTIVITY RESTRICTED AND DEFERRED STOCK UNITS

   

Restricted

and Deferred

Stock Units

   

Weighted

Average

Grant-Date

Fair Value

Per Share

 
Balance at April 30, 2025     586,461     $ 9.60  
Granted     -       -  
Vested and converted     -       -  
Balance at July 31, 2025     586,461     $ 9.60  
SCHEDULE OF STOCK OPTION ACTIVITY

The following is a summary of the Company’s stock option activity during the three months ended July 31, 2025:

 

SCHEDULE OF STOCK OPTION ACTIVITY

   

Number of

Options

   

Weighted

Average

Exercise

Price

   

Weighted

Average

Remaining

Contractual

Life

(Years)

 
Balance at April 30, 2025     458,670     $ 6.86       3.77  
Granted                  
Exercised     (5,179 )     7.65       4.52  
Forfeited                  
Cancelled     (2,500 )     7.52       4.79  
Balance at July 31, 2025     450,991       6.85       3.51  
                         
Options exercisable at end of period     386,428     $ 6.71          
Options expected to vest     64,563     $ 7.65          
Weighted average fair value of options granted during the period           $          
SCHEDULE OF STOCK BASED EXPENSE FOR STOCK OPTION

Stock-based expense for stock options were recorded in the following amounts as reflected in the unaudited condensed consolidated statements of operations:

 

SCHEDULE OF STOCK BASED EXPENSE FOR STOCK OPTION

    For the three months ended July 31, 2025     For the three months ended July 31, 2024  
Compensation and related taxes — general and administrative   $ 43,071     $ 7,402  
Professional and consulting fees     36,675       -  
Total   $ 79,746     $ 7,402  
SCHEDULE OF STOCK WARRANT ACTIVITY

A summary of the Company’s outstanding warrants to purchase shares of common stock as of July 31, 2025, and the changes during the period are presented below:

 

SCHEDULE OF STOCK WARRANT ACTIVITY

   

Number of

Warrants

   

Weighted

Average

Exercise

Price

   

Weighted

Average

Remaining

Contractual

Life

(Years)

 
                   
Balance at April 30, 2025     4,443,444     $ 7.30       2.93  
Granted                  
Exercised     (1,663,384 )     6.21       2.97  
Forfeited                  
Canceled                  
Total Warrants Outstanding at July 31, 2025     2,780,060     $ 7.95       2.51  
Warrants exercisable at end of period     2,780,060     $ 7.95       2.51  
Weighted average fair value of warrants granted during the period           $